Intranasal Placebo: Clinical Trials

3 trials of Intranasal Placebo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Recruiting 2, Completed 1
Phase 21Recruiting 1

Follow Intranasal Placebo: new trials by email Literature Review of Intranasal Placebo trials Research Report on Intranasal Placebo

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exercise and Intranasal Insulin in Type 2 Diabetes
Intranasal Insulin, Intranasal Placebo, High Intensity Exercise - Type 2 Diabetes, Insulin Sensitivity/Resistance
Phase 2 / Phase 3RecruitingRutgers, The State University of New Jersey602026-08-032026-06-30
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Esketamine, Midazolam, Oral Placebo - Depressive Disorder, Major
Phase 3RecruitingJanssen Research & Development, LLC2582026-01-082026-09-25
Safety and Efficacy of Multiple Doses of Intranasal Ketorolac in Postoperative Pain Following Major Abdominal Surgery
Intranasal Ketorolac Tromethamine, Intranasal Placebo - Postoperative Pain
Phase 3CompletedEgalet Ltd3212005-12-012017-02-08

Conditions studied

Depressive Disorder, Major (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Insulin Resistance (1)  ·  Pain, Postoperative (1)

Sponsors

Egalet Ltd (1)  ·  Janssen Research & Development, LLC (1)  ·  Rutgers, The State University of New Jersey (1)

Countries

United States (3)  ·  Brazil (1)  ·  Hungary (1)  ·  Italy (1)  ·  New Zealand (1)  ·  Romania (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Lincoln Bynum, MD (1)  ·  Steven K Malin, PhD (1)

NIH funding

R01DK147509 (1)